ANDERSON HOAGLAND & CO – SPDR S&P Biotech ETF Transaction History
ANDERSON HOAGLAND & CO portfolio value:
$2.63M
portfolio value
ANDERSON HOAGLAND & CO quarter portfolio value change:
+6.80%
quarter
SPDR S&P Biotech ETF 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +102.70% | 16.79K shares | 1.26M | $79.32 | 33.15K |
Q2 2022 | share | Decrease | -37.80% | -9.93K shares | -998K | $74.27 | 16.35K |
Q1 2022 | share | Increase | +0.08% | 21 shares | -57K | $89.88 | 26.29K |
Q4 2021 | share | Increase | +1.11% | 289 shares | -846K | $113.24 | 26.27K |
Q3 2021 | share | Increase | +4.15% | 1.03K shares | -112K | $125.71 | 25.98K |
Q2 2021 | share | Increase | +1.76% | 432 shares | 52K | $135.4 | 24.94K |
Q1 2021 | share | Decrease | -7.36% | -1.94K shares | -400K | $135.65 | 24.51K |
Q4 2020 | share | Increase | 0.00% | 26.46K shares | 3.72M | $140.74 | 26.46K |